MR-proADM (mid-regional pro-adrenomedullin) shows promise for CHF (chronic heart failure) screening
This article was originally published in Clinica
Executive Summary
A precursor of the chronic heart failure (CHF) marker adrenomedullin (ADM) is a powerful new predictor of mortality in patients suffering from the condition, and provides doctors with a good candidate for screening tests.